Yu Waye Chu

Chief Tech/Sci/R&D Officer presso CYTOMX THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 31/03/2024

56 anni

Health Technology

Consumer Services

Posizioni attive di Yu Waye Chu

Società	Posizione	Inizio	Fine
CYTOMX THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	17/07/2023	-

Società	Posizione	Inizio	Fine
FATE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	18/04/2019	14/07/2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01/01/2009	01/04/2019

Princeton University	Undergraduate Degree
University of Rochester School of Medicine & Dentistry	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
FATE THERAPEUTICS, INC.	Health Technology
CYTOMX THERAPEUTICS, INC.	Health Technology

Aziende private	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Aziende private

Health Technology